GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Epitomee Medical Ltd (XTAE:EPIT) » Definitions » EV-to-EBITDA

Epitomee Medical (XTAE:EPIT) EV-to-EBITDA : 0.12 (As of May. 27, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Epitomee Medical EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Epitomee Medical's enterprise value is ₪-2.24 Mil. Epitomee Medical's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was ₪-18.24 Mil. Therefore, Epitomee Medical's EV-to-EBITDA for today is 0.12.

The historical rank and industry rank for Epitomee Medical's EV-to-EBITDA or its related term are showing as below:

XTAE:EPIT' s EV-to-EBITDA Range Over the Past 10 Years
Min: -0.01   Med: 0.61   Max: 1.42
Current: 0.12

During the past 6 years, the highest EV-to-EBITDA of Epitomee Medical was 1.42. The lowest was -0.01. And the median was 0.61.

XTAE:EPIT's EV-to-EBITDA is ranked better than
94.88% of 488 companies
in the Medical Devices & Instruments industry
Industry Median: 16.205 vs XTAE:EPIT: 0.12

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-27), Epitomee Medical's stock price is ₪3.716. Epitomee Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ₪-0.702. Therefore, Epitomee Medical's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Epitomee Medical EV-to-EBITDA Historical Data

The historical data trend for Epitomee Medical's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Epitomee Medical EV-to-EBITDA Chart

Epitomee Medical Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial - - -22.24 -3.34 0.18

Epitomee Medical Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only -22.24 - -3.34 - 0.18

Competitive Comparison of Epitomee Medical's EV-to-EBITDA

For the Medical Devices subindustry, Epitomee Medical's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Epitomee Medical's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Epitomee Medical's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Epitomee Medical's EV-to-EBITDA falls into.



Epitomee Medical EV-to-EBITDA Calculation

Epitomee Medical's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=-2.242/-18.241
=0.12

Epitomee Medical's current Enterprise Value is ₪-2.24 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Epitomee Medical's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was ₪-18.24 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Epitomee Medical  (XTAE:EPIT) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Epitomee Medical's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=3.716/-0.702
=At Loss

Epitomee Medical's share price for today is ₪3.716.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Epitomee Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ₪-0.702.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Epitomee Medical EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Epitomee Medical's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Epitomee Medical (XTAE:EPIT) Business Description

Traded in Other Exchanges
Address
Tarshish 19, Caesarea, ISR, 3088900
Epitomee Medical Ltd is engaged in developing and commercializing ingestible therapeutic devices.

Epitomee Medical (XTAE:EPIT) Headlines

No Headlines